The UK BioIndustry Association (BIA) in collaboration with Tekiu Ltd, is guiding a delegation of UK decision makers from across the UK biotech ecosystem to explore the Swiss biotechnology sector.

The delegation is made up of representatives from industry, government and the regulatory authorities who will all be meeting with their Swiss counterparts to see how Switzerland operates outside the EU and see what lessons can be learned for the UK. In view of Brexit, it is timely to examine the policies that allow both big and small businesses in Switzerland’s Life Sciences sector to flourish. Alongside BIA member companies, the delegation will include representatives from the Office for Life Sciences and the MHRA. The trip will also offer BIA members the chance to explore new business opportunities in Switzerland.

BIA CEO, Steve Bates, said: “This trip offers organisations from across the UK’s vibrant UK bioscience ecosystem to meet with potential collaborators and learn from innovative solutions within biotechnology. It will be particularly interesting to learn about Swiss policies that promote biotech development, including tax and regulation to see whether any of these polices can be replicated in the UK to support UK bioscience businesses.”

Switzerland has a very different political system to the UK with a lot of decentralised power across the 26 cantons, which have some autonomy over issues that have an impact on the industry such as regulation and taxes. Learning about such a different way of operating will offer potential lessons that the UK could explore in the future.

Ted Fjallman, Executive Director of Tekiu Ltd said: “This delegation will help to build relationships between the delegates themselves and with their counterparts in Switzerland, and will allow them to gain new perspectives and to explore subjects in depth. Often all the representatives on this group would only meet once or twice a year and this visit will allow them to experience things together, have conversations about key issues for the sector and to synthesise the information from the hosts.”

The delegation will cover off some key issues that are relevant to the sector including technology transfer and will visit the tech transfer office at ETH University where they will learn different perspectives on how tech transfer works in Switzerland from representatives from academia and industry.

Representatives for the UK will meet a cross section of Swiss companies from SME’s such as Zurich based NeurImmune up to larger pharmaceutical companies like Novartis where they will meet experts from regulatory affairs, strategy and innovation and venture funding on a tour of the Novartis campus in Basel.

On the last day of the visit there will be a workshop for delegates to come together to discuss all of their individual learnings from the trip and discuss how any learnings can be implemented on their return to the UK.

The BIA will update on the delegation on the BIA blog.

About Tekiu

Tekiu is a knowledge transfer broker focusing on bespoke international visits for delegates from industry, government and academia. Tekiu’s vision is a world where companies, organisations and governments are actively engaging with their counterparts internationally to benchmark and learn from each other’s successes and failures. Tekiu has specific technical expertise and contacts in healthcare and biotech, environmental science, engineering disciplines, as well as education and innovation management. Geographically, the company focuses on the UK, Scandinavia and German-speaking countries.